Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
2,819
NCT02350270
Gait, cOgnitiOn & Decline (GOOD)
Phase: N/A
Role: Collaborator
Start: Jan 31, 2015
Completion: Dec 31, 2015
NCT04899115
VE303 for Treatment of Hepatic Encephalopathy (HE)
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 6, 2021
Completion: Aug 30, 2023